Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Valvular Heart Disease

Free Subscription Articles published in Circulation Retrieve available abstracts of 116 articles: HTML format

Single Articles

June 2026
1. LINDMAN BR, Gillam LD, Perpetua EM, Elmariah S, et al
   Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.
   Circulation. 2026 Jun 26. doi: 10.1161/CIRCULATIONAHA.126.081405.
   PubMed     Abstract available
   
   
   
2. MOURA-FERREIRA S, Pugliese NR, Verwerft J
   Response by Moura-Ferreira et al Regarding Article, "Prognostic Value of Exercise Right Ventricular-Pulmonary Arterial Coupling in Primary Mitral Regurgitation".
   Circulation. 2026;153:e1392-e1393.
   PubMed    
   
   
   
3. BADANO LP, Tomaselli M, Caravita S
   Letter by Badano et al Regarding Article, "Prognostic Value of Exercise Right Ventricular-Pulmonary Arterial Coupling in Primary Mitral Regurgitation".
   Circulation. 2026;153:e1390-e1391.
   PubMed    
   
   
   May 2026
4. FERREIRA ZIMMER C, Marquard JM, Jabbari R, Sabbah M, et al
   Impact of Angina on Outcome After Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation: Insights From the NOTION-3 Trial.
   Circulation. 2026;153:1687-1690.
   PubMed    
   
   
   
5. MEHAFFEY JH, Miller DC, Kaul S, Badhwar V, et al
   Current Incidence and Modality of Young Aortic Valve Replacement in the United States.
   Circulation. 2026;153:1520-1522.
   PubMed    
   
   
   
6. DHONT S, Moura Ferreira S, Galloo X, Martens P, et al
   Angiotensin Receptor Neprilysin Inhibitor in Heart Failure with Preserved Ejection Fraction and Secondary Mitral Regurgitation: the PRAISE-MR Randomized Trial.
   Circulation. 2026 May 9. doi: 10.1161/CIRCULATIONAHA.126.080833.
   PubMed     Abstract available
   
   
   April 2026
7. ROSE D
   Letter by Rose Regarding Article, "Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis".
   Circulation. 2026;153:e1151-e1152.
   PubMed    
   
   
   
8. KANG DH
   Response by Kang to Letter Regarding Article, "Long-Term Outcomes of Early Surgery versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis".
   Circulation. 2026;153:e1153.
   PubMed    
   
   
   
9. PRZYBYLSKI R, Norrish G, Claggett B, Ashley EA, et al
   The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.
   Circulation. 2026 Apr 17. doi: 10.1161/CIRCULATIONAHA.126.078843.
   PubMed     Abstract available
   
   
   
10. VISSING CR, Axelsson Raja A, Helms AS, Saberi S, et al
    Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy.
    Circulation. 2026;153:1104-1116.
    PubMed     Abstract available
    
    
    March 2026
11. LIN B, Wang J, Li C, Wang S, et al
    CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy.
    Circulation. 2026;153:845-862.
    PubMed     Abstract available
    
    
    
12. KAR S
    Response by Kar to Letter Regarding Article, "Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial".
    Circulation. 2026;153:e937.
    PubMed    
    
    
    
13. SUN P
    Letter by Sun Regarding Article, "Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial".
    Circulation. 2026;153:e936.
    PubMed    
    
    
    
14. ZHANG X, Hao Y, Han D, Jin X, et al
    PRMT3-Mediated Arginine Methylation Stabilizes PCSK9 to Promote Aortic Valve Calcification.
    Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078830.
    PubMed     Abstract available
    
    
    February 2026
15. THERIAULT S, Holdcraft JA, Sharipova D, Faucherre A, et al
    Genome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.074752.
    PubMed     Abstract available
    
    
    
16. ARNOLD SV, Spertus JA, Gosch K, Dunlay SM, et al
    Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study.
    Circulation. 2026;153:310-318.
    PubMed     Abstract available
    
    
    January 2026
17. BATTISTOLO Q, Avvedimento M, Guerin P, Turgeon PY, et al
    Multivalve Involvement in Aortic Stenosis: Insights From a Narrative Review.
    Circulation. 2026;153:115-131.
    PubMed     Abstract available
    
    
    
18. PARK SJ, Kim M, Son J, Jo HH, et al
    Correction to: Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.
    Circulation. 2026;153:e12.
    PubMed    
    
    
    
19. TANGUTURI VK, Elmariah S
    Response by Tanguturi and Elmariah to Letter Regarding Article, "Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial".
    Circulation. 2026;153:e2-e3.
    PubMed    
    
    
    
20. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial".
    Circulation. 2026;153:e1.
    PubMed    
    
    
    December 2025
21. XU A, Weissman D, Ermer KJ, Bertero E, et al
    Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.
    Circulation. 2025;152:1705-1727.
    PubMed     Abstract available
    
    
    
22. GIRI J, Nathan AS
    Transcatheter Aortic Valve Replacement With Local Anesthesia: When Less Is Less?
    Circulation. 2025;152:1538-1540.
    PubMed    
    
    
    November 2025
23. MARGONATO D, Enriquez-Sarano M, Nishihara T, Phichaphop A, et al
    Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance.
    Circulation. 2025 Nov 12. doi: 10.1161/CIRCULATIONAHA.125.074862.
    PubMed     Abstract available
    
    
    
24. MOURA-FERREIRA S, Pugliese NR, Milani M, Taddei S, et al
    Prognostic Value of Exercise Right Ventricular-Pulmonary Arterial Coupling in Primary Mitral Regurgitation.
    Circulation. 2025 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.073778.
    PubMed     Abstract available
    
    
    October 2025
25. ADAMS DH, Pandis D
    Expert Hands, Favorable Curves: Parsing the Evidence for Early Mitral Valve Repair.
    Circulation. 2025;152:1218-1220.
    PubMed    
    
    
    
26. SCHWANN TA, Habib RH, Saadat S, Abbas AE, et al
    Surgery for Periprocedural Failure of Transcatheter Aortic Valve Replacement in the United States.
    Circulation. 2025;152:1262-1264.
    PubMed    
    
    
    
27. GARCIA HERNANDEZ S, de la Higuera Romero L, Fernandez A, Luisa Pena Pena M, et al
    Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.
    Circulation. 2025;152:1060-1075.
    PubMed     Abstract available
    
    
    
28. CAMPAIN J, Griskowitz C, Newlands C, Claggett BL, et al
    Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.
    Circulation. 2025;152:990-1002.
    PubMed     Abstract available
    
    
    September 2025
29. AYUBA G, Bhatt A, Bavry A
    Percutaneous Solutions for Tricuspid Regurgitation: Current Approved Options and Identifying Ideal Candidates.
    Circulation. 2025;152:909-912.
    PubMed    
    
    
    
30. KRISHNASWAMY A, Reed GW
    Defining Optimal Treatment Strategies for Bicuspid Aortic Valve Stenosis With Balloon- and Self-Expandable Transcatheter Heart Valves.
    Circulation. 2025;152:658-660.
    PubMed    
    
    
    
31. WAGNILD JM, Bayliss C, Maier RH, Ogundimu E, et al
    Accelerometer-Measured Physical Activity After Mitral Valve Surgery: An Analysis of the UK Mini Mitral Randomized Controlled Trial.
    Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.074651.
    PubMed     Abstract available
    
    
    August 2025
32. MESSIKA-ZEITOUN D, Chu MWA, Bouchard D, Le Tourneau T, et al
    Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry.
    Circulation. 2025 Aug 31. doi: 10.1161/CIRCULATIONAHA.124.073674.
    PubMed     Abstract available
    
    
    
33. KENNEDY J, Blackman DJ, Dodd M, Poggesi A, et al
    Impact of Cerebral Embolic Protection On Cognitive Function Following Transcatheter Aortic Valve Implantation: Data From the BHF PROTECT-TAVI Randomized Trial.
    Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076761.
    PubMed     Abstract available
    
    
    
34. JORGENSEN TH, Savontaus M, Willemen Y, Bleie O, et al
    Three-Year-Follow-Up of the NOTION-2 Trial: TAVR Versus SAVR to Treat Younger Low-Risk Patients with Tricuspid or Bicuspid Aortic Stenosis.
    Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076678.
    PubMed     Abstract available
    
    
    
35. FEISTRITZER HJ, Ender J, Lauten P, Rudolph TK, et al
    Peri-interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Non-inferiority Trial.
    Circulation. 2025 Aug 29. doi: 10.1161/CIRCULATIONAHA.125.076557.
    PubMed     Abstract available
    
    
    
36. GIACOPPO D, Alvarez-Covarrubias H, Xhepa E, Matsuda Y, et al
    Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis.
    Circulation. 2025 Aug 18. doi: 10.1161/CIRCULATIONAHA.124.069323.
    PubMed     Abstract available
    
    
    
37. PARK SJ, Kim M, Son J, Jo HH, et al
    Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.
    Circulation. 2025 Aug 13. doi: 10.1161/CIRCULATIONAHA.125.074560.
    PubMed     Abstract available
    
    
    June 2025
38. GENEREUX P, Lindman BR, Pibarot P
    New Classification to Describe Clinical Presentation in Aortic Stenosis: Stable, Progressive, and Acute Valve Syndrome.
    Circulation. 2025;151:1627-1629.
    PubMed    
    
    
    
39. BERRY JD, de Lemos JA
    Biomarkers to Guide the Timing of Aortic Valve Replacement in Asymptomatic Aortic Stenosis: Where Do We Stand After Early TAVR?
    Circulation. 2025;151:1565-1567.
    PubMed    
    
    
    May 2025
40. PRABHU NK, Aykut B, Mensah-Mamfo M, Overbey DM, et al
    Partial Heart Transplantation: Early Experience With Pediatric Heart Valve Replacements That Grow.
    Circulation. 2025;151:1477-1490.
    PubMed     Abstract available
    
    
    
41. DESAI MY, Wolski K, Owens A, Geske JB, et al
    Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM.
    Circulation. 2025;151:1378-1390.
    PubMed     Abstract available
    
    
    
42. METRA M, Tomasoni D, Adamo M, Anker SD, et al
    Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions.
    Circulation. 2025;151:1342-1363.
    PubMed     Abstract available
    
    
    April 2025
43. VEKSTEIN AM, Wegermann ZK, Manandhar P, Mack MJ, et al
    Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry.
    Circulation. 2025 Apr 3. doi: 10.1161/CIRCULATIONAHA.124.071838.
    PubMed     Abstract available
    
    
    March 2025
44. LINDMAN BR, Pibarot P, Schwartz A, Oldemeyer JB, et al
    Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial.
    Circulation. 2025 Mar 31. doi: 10.1161/CIRCULATIONAHA.125.074425.
    PubMed     Abstract available
    
    
    
45. TANGUTURI VK, Abou-Karam R, Cheng F, Duan R, et al
    Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: a Randomized Clinical Trial.
    Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074470.
    PubMed     Abstract available
    
    
    
46. KAR S, Makkar RR, Whisenant BK, Hamid N, et al
    Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial.
    Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074536.
    PubMed     Abstract available
    
    
    
47. MEISNER JK, Renberg A, Smith ED, Tsan YC, et al
    Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.
    Circulation. 2025;151:783-798.
    PubMed     Abstract available
    
    
    February 2025
48. ROSA M, Dupont A, Smadja DM, Soquet J, et al
    Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug Repositioning.
    Circulation. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.124.071954.
    PubMed     Abstract available
    
    
    
49. ZHANG B, Enriquez-Sarano M, Schaff HV, Michelena HI, et al
    Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy.
    Circulation. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.123.066523.
    PubMed     Abstract available
    
    
    January 2025
50. PARK SJ, Kang DH
    Response by Park and Kang to Letter Regarding Article, "Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
    Circulation. 2025;151:e28.
    PubMed    
    
    
    
51. WANG J, Peng Y
    Letter by Wang and Peng Regarding Article, "Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
    Circulation. 2025;151:e27.
    PubMed    
    
    
    
52. GUDMUNDSDOTTIR HL, Axelsson Raja A, Rossing K, Rasmusen H, et al
    Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial.
    Circulation. 2025;151:132-144.
    PubMed     Abstract available
    
    
    December 2024
53. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
    Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
    Circulation. 2024;150:2046-2069.
    PubMed     Abstract available
    
    
    November 2024
54. URENA M
    Transseptal Transcatheter Valve-in-Valve Mitral Valve Implantation: Ready for Prime Time.
    Circulation. 2024;150:1505-1507.
    PubMed    
    
    
    October 2024
55. RUDOLPH F, Geyer M, Baldus S, De Luca VM, et al
    Transcatheter Repair Versus Surgery for Atrial Versus Ventricular Functional Mitral Regurgitation - a Post-hoc Analysis of the MATTERHORN Trial.
    Circulation. 2024 Oct 30. doi: 10.1161/CIRCULATIONAHA.124.072648.
    PubMed    
    
    
    
56. WEDIN JO, Naslund V, Rodin S, Simonson OE, et al
    Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis.
    Circulation. 2024 Oct 23. doi: 10.1161/CIRCULATIONAHA.124.070753.
    PubMed     Abstract available
    
    
    
57. MAURIZI N, Antiochos P, Owens A, Lakdwala N, et al
    Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry.
    Circulation. 2024;150:1377-1390.
    PubMed     Abstract available
    
    
    
58. BENKHOFF M, Barcik M, Mourikis P, Dahlmanns J, et al
    Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease.
    Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.123.067270.
    PubMed     Abstract available
    
    
    
59. HOEDEMAKERS S, Cosyns B, Droogmans S, Verbrugge FH, et al
    Response by Hoedemakers et al to Letter Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis".
    Circulation. 2024;150:e278-e279.
    PubMed    
    
    
    
60. JHA AK
    Letter by Jha Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis".
    Circulation. 2024;150:e276-e277.
    PubMed    
    
    
    September 2024
61. SANNINO A, Mahkmudova U
    Artificial Intelligence and Mitral Regurgitation: Friend or Foe?
    Circulation. 2024;150:934-937.
    PubMed    
    
    
    
62. 
    Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;150:e267.
    PubMed    
    
    
    
63. CRIBIER A, Eltchaninoff H
    Transcatheter Aortic Valve Implantation: Two Decades of a Revolutionary and Ongoing Odyssey.
    Circulation. 2024;150:821-822.
    PubMed    
    
    
    
64. RAMO J, Jurgens SJ, Kany S, Choi SH, et al
    Rare Genetic Variants in LDLR, APOB, and PCSK9 are Associated with Aortic Stenosis.
    Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.070982.
    PubMed     Abstract available
    
    
    August 2024
65. SHRIDHAR P, Pal S, Clavere NG, Becker JR, et al
    Response by Shridhar et al to Letter Regarding Article, "MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy".
    Circulation. 2024;150:e201-e202.
    PubMed    
    
    
    
66. DAVID TE
    Perspectives on Heart Valve Repair.
    Circulation. 2024;150:661-662.
    PubMed    
    
    
    
67. SUN Y, Ren J
    Letter by Sun and Ren Regarding Article, "MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy".
    Circulation. 2024;150:e200.
    PubMed    
    
    
    
68. VRUDHULA A, Duffy G, Vukadinovic M, Liang D, et al
    High-Throughput Deep Learning Detection of Mitral Regurgitation.
    Circulation. 2024 Aug 12. doi: 10.1161/CIRCULATIONAHA.124.069047.
    PubMed     Abstract available
    
    
    
69. GOEL K, Makkar R, Krishnaswamy A, Kapadia S, et al
    Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States.
    Circulation. 2024 Aug 5. doi: 10.1161/CIRCULATIONAHA.124.068847.
    PubMed     Abstract available
    
    
    July 2024
70. CARRIER L
    RNA Editing Holds Promise for Hypertrophic Cardiomyopathy Therapy.
    Circulation. 2024;150:299-301.
    PubMed    
    
    
    
71. YANG P, Lou Y, Geng Z, Guo Z, et al
    Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy.
    Circulation. 2024;150:283-298.
    PubMed     Abstract available
    
    
    June 2024
72. LONG A, Haggerty CM, Finer J, Hartzel D, et al
    Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation (DELINEATE-MR).
    Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.124.068996.
    PubMed     Abstract available
    
    
    
73. SMALL AM, Yutzey KE, Binstadt BA, Voigts Key K, et al
    Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Jun 17. doi: 10.1161/CIR.0000000000001254.
    PubMed     Abstract available
    
    
    
74. QUAST C, Bonner F, Polzin A, Veulemans V, et al
    Aortic Valve Stenosis Causes Accumulation of Extracellular Hemoglobin and Systemic Endothelial Dysfunction.
    Circulation. 2024 Jun 5. doi: 10.1161/CIRCULATIONAHA.123.064747.
    PubMed     Abstract available
    
    
    
75. MCGURK KA, Bilgehan N, Ware JS
    Pharmacogenetic Influences Over Mavacamten Pharmacokinetics: Considerations for the Treatment of Individuals With Hypertrophic Cardiomyopathy.
    Circulation. 2024;149:1786-1788.
    PubMed    
    
    
    
76. OMMEN SR, Ho CY, Asif IM, Balaji S, et al
    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e1239-e1311.
    PubMed     Abstract available
    
    
    May 2024
77. EVANGELISTA A, Galian-Gay L, Guala A, Teixido-Tura G, et al
    Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.123.067537.
    PubMed     Abstract available
    
    
    
78. KANG DH, Park SJ, Shin SH, Hwang IC, et al
    Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial.
    Circulation. 2024 May 1. doi: 10.1161/CIRCULATIONAHA.124.069144.
    PubMed     Abstract available
    
    
    April 2024
79. SHEN M, Wu JC
    Empowering Valvular Heart Disease Research With Stem Cell-Derived Valve Cells.
    Circulation. 2024;149:1457-1460.
    PubMed    
    
    
    
80. DAVIDSON LJ, Tang GHL, Ho EC, Fudim M, et al
    The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 25. doi: 10.1161/CIR.0000000000001232.
    PubMed     Abstract available
    
    
    
81. LI B, Liu F, Chen X, Chen T, et al
    FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System.
    Circulation. 2024;149:1268-1284.
    PubMed     Abstract available
    
    
    February 2024
82. HERRMANN HC, Desai ND
    Incidence, Implications, and Treatment of Patients With Severe Aortic Stenosis and Small Aortic Annulus.
    Circulation. 2024;149:656-657.
    PubMed    
    
    
    
83. HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al
    mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
    Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130.
    PubMed     Abstract available
    
    
    
84. CRESCI S, Bach RG, Saberi S, Owens AT, et al
    Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.
    Circulation. 2024;149:498-509.
    PubMed     Abstract available
    
    
    January 2024
85. HAN D, Zhou T, Li L, Ma Y, et al
    AVCAPIR: A Novel Procalcific PIWI-Interacting RNA in Calcific Aortic Valve Disease.
    Circulation. 2024 Jan 23. doi: 10.1161/CIRCULATIONAHA.123.065213.
    PubMed     Abstract available
    
    
    
86. TOPRICEANU CC, Pereira AC, Moon JC, Captur G, et al
    Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy.
    Circulation. 2024;149:107-123.
    PubMed     Abstract available
    
    
    December 2023
87. SHRIDHAR P, Glennon MS, Pal S, Waldron CJ, et al
    MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1870-1886.
    PubMed     Abstract available
    
    
    November 2023
88. LIN Y, Yang Q, Lin X, Liu X, et al
    Extracellular Matrix Disorganization Caused by ADAMTS16 Deficiency Leads to Bicuspid Aortic Valve With Raphe Formation.
    Circulation. 2023 Nov 29. doi: 10.1161/CIRCULATIONAHA.123.065458.
    PubMed     Abstract available
    
    
    
89. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
    Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1797-1811.
    PubMed     Abstract available
    
    
    
90. SEO K, Yamamoto Y, Kirillova A, Kawana M, et al
    Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
    Circulation. 2023;148:1691-1704.
    PubMed     Abstract available
    
    
    
91. 
    Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023;148:e185.
    PubMed    
    
    
    
92. ROGERS MA, Bartoli-Leonard F, Zheng KH, Small AM, et al
    Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.
    Circulation. 2023 Nov 8. doi: 10.1161/CIRCULATIONAHA.123.066822.
    PubMed     Abstract available
    
    
    October 2023
93. RODES-CABAU J, Ribeiro H, Mohammadi S, Serra V, et al
    Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial.
    Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.067326.
    PubMed     Abstract available
    
    
    
94. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    PubMed     Abstract available
    
    
    
95. DAHLE G, Al-Atassi T, Kaneko T
    The Future of Cardiac Surgical Training in the Age of Transcatheter Valvular Interventions.
    Circulation. 2023;148:1295-1297.
    PubMed    
    
    
    
96. HARIRI E, Kassis N, Kapadia SR
    Letter by Hariri et al Regarding Article, "Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial".
    Circulation. 2023;148:1267-1268.
    PubMed    
    
    
    
97. HASIFIC S, Rasmussen LM, Dahl JS, Diederichsen ACP, et al
    Response by Hasific et al to Letter Regarding Article, "Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial".
    Circulation. 2023;148:1269-1270.
    PubMed    
    
    
    September 2023
98. JEX N, Greenwood JP, Cubbon RM, Rider OJ, et al
    Association Between Type 2 Diabetes and Changes in Myocardial Structure, Contractile Function, Energetics, and Blood Flow Before and After Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
    Circulation. 2023 Sep 25. doi: 10.1161/CIRCULATIONAHA.122.063444.
    PubMed     Abstract available
    
    
    
99. FIGLIOZZI S, Georgiopoulos G, Masci PG
    Letter by Figliozzi et al Regarding Article, "The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum".
    Circulation. 2023;148:978-979.
    PubMed    
    
    
    
100. ESSAYAGH B, Benfari G, Antoine C, Grigioni F, et al
     Response by Essayagh et al to Letter Regarding Article, "The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum".
     Circulation. 2023;148:980-981.
     PubMed    
     
     
     
101. AYERS MP, Kramer CM
     Imaging Myofibrillar Disarray and Microvascular Dysfunction in Hypertrophic Cardiomyopathy: Novel Imaging Biomarkers for a New Era in Therapeutics.
     Circulation. 2023;148:819-821.
     PubMed    
     
     
     
102. JOY G, Kelly CI, Webber M, Pierce I, et al
     Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
     Circulation. 2023;148:808-818.
     PubMed     Abstract available
     
     
     August 2023
103. REINDL M, Lechner I, Holzknecht M, Tiller C, et al
     Cardiac Magnetic Resonance Imaging Versus Computed Tomography to Guide Transcatheter Aortic Valve Replacement (TAVR-CMR): A Randomized, Open-Label, Non-Inferiority Trial.
     Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066498.
     PubMed     Abstract available
     
     
     
104. PRAKASH SK, Michelena HI, Milewicz DM
     Bicuspid Aortic Valve and Thoracic Aortic Disease: Further Evidence of Clinically Silent but Deadly Risk to Family Members of Affected Individuals.
     Circulation. 2023;148:648-650.
     PubMed    
     
     
     
105. 
     Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2023;148:e8.
     PubMed    
     
     
     
106. ABOU ALAIWI S, Roston TM, Marstrand P, Claggett BL, et al
     Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
     Circulation. 2023;148:394-404.
     PubMed     Abstract available
     
     
     July 2023
107. ARMSTRONG DWJ, Riley LA, Su YR, Shah AS, et al
     Myocardial Neprilysin Is Increased in Hypertrophic Cardiomyopathy.
     Circulation. 2023;148:167-169.
     PubMed    
     
     
     
108. BLASER MC, Buffolo F, Halu A, Turner ME, et al
     Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of Atherosclerosis and Calcific Aortic Valve Stenosis.
     Circulation. 2023 Jul 10. doi: 10.1161/CIRCULATIONAHA.122.063402.
     PubMed     Abstract available
     
     
     
109. MONDA E, Limongelli G
     Letter by Monda and Limongelli Regarding Article, "The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy".
     Circulation. 2023;148:73.
     PubMed    
     
     
     June 2023
110. GLOTZBACH JP, Hanson HA, Tonna JE, Horns JJ, et al
     Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database.
     Circulation. 2023 Jun 15. doi: 10.1161/CIRCULATIONAHA.122.060439.
     PubMed     Abstract available
     
     
     May 2023
111. GALPER BZ, Chinnakondepalli KM, Wang K, Magnuson EA, et al
     Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.
     Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.062481.
     PubMed     Abstract available
     
     
     April 2023
112. GOLLMANN-TEPEKOYLU C, Graber M, Hirsch J, Mair S, et al
     Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification.
     Circulation. 2023 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.063481.
     PubMed     Abstract available
     
     
     March 2023
113. RAKOWSKI H, Bataiosu R
     Can Novel Myosin Inhibitors Defer Septal Reduction Therapy in HCM? At What Risk and at What Cost?
     Circulation. 2023;147:864-866.
     PubMed    
     
     
     
114. DESAI MY, Owens A, Geske JB, Wolski K, et al
     Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks.
     Circulation. 2023;147:850-863.
     PubMed     Abstract available
     
     
     February 2023
115. TURER AT, Wang A
     Cardiac Myosin Inhibitors: Unlocking Potential to Improve Treatment in Hypertrophic Cardiomyopathy.
     Circulation. 2023;147:700-702.
     PubMed    
     
     
     
116. CONWAY J, Min S, Villa C, Weintraub RG, et al
     The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
     Circulation. 2023;147:718-727.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum